News
3don MSN
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
Moderna's candidate COVID-19 vaccine is even more effective than Pfizer's, trial results show, a "light at the end of the tunnel" for the pandemic.
In the Moderna trial, 90 of the first 95 participants to develop COVID-19 had received the placebo and only five the active vaccine, so it was 94.5% effective. Results from another 56 participants ...
Investors were seemingly buoyed by Moderna's vaccine trial results, with U.S. stock futures on Monday pointing to a strong opening. Dow futures were up 476 points, or 1.6%, before the start of trade.
HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...
Moderna will keep its COVID vaccine on the market at no cost to consumers, even after the federal government stops paying for it, the company announced Wednesday. "Everyone in the United States ...
Moderna’s Covid Vaccine: What You Need to Know Denise Grady Published Nov. 16, 2020 Updated Nov. 30, 2020 Share full article ...
Moderna says a new version of the company's COVID-19 vaccine appears to be highly effective against the omicron variant. Now to the ongoing fight against the coronavirus. Today, the drug company ...
A second coronavirus vaccine has now joined the fight against COVID-19 in the United States. On December 18, the U.S. Food and Drug Administration authorized Moderna’s vaccine for emergency use ...
COVID vaccine maker Pfizer Inc. lost 0.6%, while its partner BioNTech, shed 3.8%. Moderna’s latest efficacy data hasn’t been published in a medical journal and further details weren’t released.
Moderna also announced that it has initiated a submission to the FDA for emergency use authorization of the company’s Covid-19 vaccine for children ages 6 through 11 years old. Children that age ...
Coronavirus Updates What It Was Like To Participate In The Clinical Trial For Moderna's COVID-19 Vaccine Pfizer applied for emergency use authorization on Nov. 9 for its COVID-19 vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results